Return to content in this issue

 

Efficacy of Benralizumab and Clinical Course of Igg4 on Eosinophilic Granulomatosis with Polyangiitis

Miyata Y, Inoue H, Homma T, Tanaka A, Sagara H

Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan

J Investig Allergol Clin Immunol 2021; Vol. 31(4)
doi: 10.18176/jiaci.0648

Key words: EGPA, Benralizumab, Ant i-IL-5 receptor antibody, IgG4, MPO-ANCA